Abstract
Myasthenia gravis (MG) patients with antibodies against the muscle specific tyrosine kinase (MuSK +) have predominantly involvement of cranio-bulbar muscles and do not display thymus pathology, as do acetylcholine receptor antibody seropositive (AChR +) MG patients. In search of novel biomarkers for MuSK + MG, we evaluated circulating serum microRNAs. Four analyzed microRNAs were specifically elevated in MuSK + MG patient serum samples: let-7a-5p, let-7f-5p, miR-151a-3p and miR-423-5p. The circulating microRNA profile in MuSK. + MG differs from the profile previously observed in the serum of AChR + MG, thus indicating the etiological difference between these two entities. We propose that the identified microRNAs could serve as potential serum biomarkers for MuSK + MG.
Lingua originale | English |
---|---|
pagine (da-a) | 21-26 |
Numero di pagine | 6 |
Rivista | Journal of Neuroimmunology |
Volume | 292 |
DOI | |
Stato di pubblicazione | Pubblicato - 2016 |
Keywords
- Adult
- Aged, 80 and over
- Anti-Inflammatory Agents
- Autoantibodies
- Biomarker
- Case-Control Studies
- Electromyography
- Female
- Humans
- Immunology
- Immunology and Allergy
- Let-7
- MG
- Male
- MicroRNA
- MicroRNAs
- Middle Aged
- MuSK
- Muscle specific tyrosine kinase
- Myasthenia Gravis
- Myasthenia gravis
- Neurology
- Neurology (clinical)
- Prednisone
- RNA, Messenger
- ROC Curve
- Receptors, Cholinergic
- Young Adult